Renaissance HotelBrussels - Rue du Parnasse 19

27 June 201813:00 - 15:00

Improving prevention,diagnosis and clinicalmanagement

SEPSIS

About the ENSHThe European Network for Safer Healthcare is an informal group of health stakeholders working together to ensure patient and healthcare workforce safety is in the limelight of the EU policy agenda. Implementing the highest standards of safety for patients and the health workforce is the cornerstone of an effective health system and an indicator of quality of care.

The direct cost of unsafe care is about EUR 21 billion or 1.5 % of health expenditure for EU countries. Investing in safer healthcare will prevent 260 000 fewer incidents of permanent disability, and 95 000 fewer deaths per year. It is vitally important that safety in the healthcare system is safeguarded when devising policy responses to pressing health needs. For more information: www.eusaferhealthcare.eu

ENSH Members

About Sepsis

This project was made possible thanks to unrestricted grants from Becton, Dickinson and Company

Sepsis arises when the body’s response to infection injures its own tissues and organs. It can lead to septic shock, multiple organ failure and death, if not recognized early and managed promptly.

In the community, sepsis often presents as the clinical deterioration of common and preventable infections such as those of the respiratory, gastrointestinal and urinary tract, or of wounds and skin. Sepsis may also result from infections acquired in health care settings. In Europe, about 80 000 hospitalized patients are es-timated to have at least one health care-associated infection on any given day. Antimicrobial resistance is a major factor determining clinical unresponsiveness to treatment and rapid evolution to sepsis and septic shock. Around 214 000 neonatal deaths due to sepsis worldwide each year could be attributable to resistant pathogens. Sepsis is frequently under-diagnosed at an early stage when it is still potentially reversible. Early diagnosis and appropriate clinical management of sepsis is crucial to increase the likelihood of survival.

It is impossible to estimate precisely the global epidemiological burden of sepsis. According to crude in-cidence estimates extrapolated from data gathered in the United States of America, there could be 15–19 million cases of sepsis every year worldwide. Further data report up to 31 and 24 million cases of sepsis and septic shock respectively globally, with clinical conditions resulting in sepsis accounting for about 6 million deaths. The financial burden due to sepsis has been calculated to be more than US$ 24 billion, representing 6.2% of total hospital costs in 2013. Studies in Europe and Canada have estimated the daily costs of hospital care of a septic patient to be between €710 and €1033 in 2000.

Source: WHO Secretariat Report A70/13 - Improving the prevention, diagnosis and clinical management of sepsis

HFE - Health First Europe

GSA - Global Sepsis Alliance

EUSEM - The European Society for Emergency Medicine

EHMA - European Health Management Association

EUNETIPS - European network to promote infection prevention for patient safety

IAPO - International Alliance of Patients’ Organizations

SpeakersMEP José Inácio Faria, Member of the European Parliament (EPP, Portugal)

José Inácio Faria is member of the Committee on the Environment, Public Health and Food Safety at the European Parliament. During his mandate, he has been working on health issues, showing a great commitment toward boosting patient safety across Europe. He also closely follows policies related to primary immunodeficiency diseases, vaccination and AMR. He is a lawyer, graduated in Portugal.

Nicola Caputo, Member of the European Parliament (S&D, Italy)

Nicola Caputo serves as member of the Committee on Agriculture and Rural Development and as substitute of the Committee on the Environment, Public Health and Food Safety at the Euro-pean Parliament. His work on health has been focused on eHealth, heart failure, patient rights, prevention and self–care. He graduated from the Faculty of Economics and Business studies at the University of Naples ‘Federico II’.

Prof. Dr. Konrad Reinhart, Global Sepsis Alliance

Prof. Dr. Konrad Reinhart is a Board certified Anaesthesiologist and Professor of Anaesthesi-ology and Intensive Care Medicine at the Jena University Hospital in Germany. He is Chair of the Global Sepsis Alliance and one of the key initiators of World Sepsis Day. As speaker of the nation-wide German research network SepNethe, he initiated landmark studies on the efficacy and safety of therapeutic approaches in sepsis as well as on the epidemiology of sepsis in Ger-many. His research activities in the field of sepsis and intensive care medicine led to more than 750 peer reviewed publications and the Research Award of the State of Thuringia (Germany).

Prof. Luis Garcia-Castrillo Riesgo, European Society for Emergency Medicine

Dr. Luis Garcia-Castrillo Riesgo has been working in the international field of Emergency Med-icine and is the President-Elect of the European Society for Emergency Medicine (EUSEM). He has developed a strong interest in the field of early detection and treatment of sepsis out of the intensive care setting. As past Professor of the Cantabria University, he has lead European pro-jects related to the role of the Syndromic Surveillance system based on the Emergency Medical Services. His research has been focused on severity models, and dissemination of structured management of the septic patient.

Mr Dennis Kredler, Patient’s Perspective

Dennis Kredler is Director of EU affairs and Head of the Brussels office of the Dow Chemical Company. He has survived sepsis a few years ago and has been campaigning to raise awareness over what he calls ‘the most preventable cause of death and disability in Europe today’.

SpeakersCharles Price, DG Health and Food Safety, European Commission

Charles Price is Policy Officer for antimicrobial resistance and healthcare-associated infections in the European Commission Unit for Crisis Management and Preparedness in Health.

Dr. Barbara Kerstiens, DG Research and Innovation, European Commission

Ms. Kerstiëns is Deputy Head of Unit responsible for infectious diseases and public health at the European Commission. She has a long experience in international public health, working for Médecins Sans Frontières, Johns Hopkins Bloomberg School of Public health and DG De-velopment and Cooperation of the European Commission prior to joining DG Research and Innovation in 2012.

Prof. Thierry Calandra, European Society of Clinical Microbiology and Infectious Diseases

Mr. Calandra is Head of the Infectious Diseases Service at the University Hospital in Lausanne and member of many medical societies, including the European Society for Clinical Microbiolo-gy and Infectious Diseases (ESCMID). For the last 20 years, Dr. Calandra’s research interests have focused on innate immunity, sepsis, bacterial and fungal infections in the intensive care unit and in immunocompromised hosts. He has published more than 250 articles, reviews, book chapters and monographs on infectious diseases, sepsis and critical care.

Prof. Daniel De Backer, European Society of Intensive Medicine

Daniel De Backer is Head of Intensive Care departments at CHIREC Hospitals (Brussels – Walloon Brabant) and Professor of Intensive Care at the Université Libre de Bruxelles. He is past-presi-dent of the European Society of Intensive Care Medicine and a member of the steering commit-tee of Surviving Sepsis Campaign. Daniel De Backer has signed more than 150 articles, serves as reviewer for 30 journals, and is Associate Editor of several journals including “Critical Care” and “Intensive Care Medicine”. His main fields of investigations are sepsis, organ dysfunction and support and circulatory failure.

Mr. Usman Khan, European Health Management Association

Mr. Khan was appointed Executive Director of the European Health Management Association in April 2016. He is also Managing Director of Modus Europe, an organisation providing strategic public policy advice, and undertakes related economic and policy studies with a particular focus on health and social care. Usman has over 20 years public policy and management experi-ence. He currently holds a non-executive position within the NHS and is Professorial Lecturer in Health Policy and Management at George Washington University.

Dr. Ricard Ferrer, Coordinator of the Project “Time to decision in Sepsis”

Dr. Ricard Ferrer is the Head of the Intensive Care Department at Vall d’Hebron Research In-stitute in Barcelona. Dr. Ferrer is a member of the Steering Committee of the Surviving Sepsis Campaign. He is actively engaged in the field of sepsis, infection prevention and treatment. In 2015, he was awarded with the Global Sepsis Awards 2015, in recognition of his contributions in the fight against sepsis worldwide. Graduated from the Medical School of the University of Barcelona, he pursued his specialisation in Intensive Care.

Dr. Vida Hamilton, National Clinical Lead Sepsis, Ireland

Vida Hamilton is the National Clinical Lead for Sepsis, sits on the National Sepsis Steering Com-mittee and co-author of the National Guidelines on Sepsis Management, also leading the im-plementation programme. She graduated from RCSI in 1995 and started training in Anaesthesia in 1996. Dr Hamilton is Honarary Senior Lecturer at the Royal College of Surgeons in Ireland and Tutor in Anaesthesia for the College of Anaesthetists. She is a Council member of the Intensive Care Society of Ireland, representing the Council at the Sepsis Section of the European Society of Intensive Care Medicine.

Other AttendeesFirst Name Last Name Organisation

Ava Lloyd American Chamber of Commerce to the EU

José Luis Gómez Becton Dickinson

Nikoleta Arnaudova Council of European Dentists

Barbara Kerstiens European Commission - DG RTD

Charles Price European Commission - DG SANTE

João Tiago De Sousa Guimaraes European Federation on Clinical chemistry and laboratory medicine

Usman Khan European Health Management Association

Teuta Azizi European Medical Students' Association

Valentina Polylas European Regional and Local Health Authorities

Marc Gheeraert European Society for Anaesthiology

Luis Garcia Castrillo European Society For Emergency Medicine

Thierry Calandra European Society of Clinical Microbiology and Infectious Diseases

Daniel De Backer European Society of Intensive Medicine

Ber Oomen European Specialist Nurses Organisations

Ilaria Giannico European Union Private Hospitals

Laura Cigolot European Alliance for Access to Safe Medicines

Jean Carlet Expert

Giulio Toccafondi Expert

Giorgio Tulli Expert

Dennis Kredler Expert

Mike Weinbren Expert

First Name Last Name Organisation

Jakub Śmiechowicz Expert

Javier Gonzalez del Castillo Expert

Marcio Borges Expert

Juan Carlos Rodriguez Expert

Catherine Cotton Federation of European Microbiological Societies (FEMS)

Konrad Reinhart Global Sepsis Alliance

Nigel Clarke General Pharmaceutical Council

Wes Himes Health First Europe

Melina Raso Health First Europe

Lucia Medori Health First Europe

Adela Maghear Health Care Without Harm Europe

Ricard Ferrer Hospital Universitari Vall d’Hebron

Albert van der Zeijden International Alliance of Patients' Organizations

Jessica Carreno Louro International Association of Mutual Benefit Societies

David Vaughan International Society for Quality in Health Care

Arianna Scenna Regione Piemonte

Annelie Zapfe Representation of the Free State of Thuringia

Els Duysburgh Sciensano

Laure Mortgat Sciensano

Sven-Olaf Kuhn University Greifswald

Alexia Verroken Université Catholique de Louvain

ContactsThe initiatives of the European Network for Safer Healthcare are coordinated and

implemented under the supervision of Health First Europe.

www.eusaferhealthcare.eu

Rue du Trone 60, First Floor, 1050 Bruxelles, Belgium

Tel: +32(0)2 626.19.99

info@healthfirsteurope.eu

Twitter: @HealthFirstEU

LinkedIn: Health First Europe

www.healthfirsteurope.eu